Status:
WITHDRAWN
Intestinal Permeability and Gastroparesis
Lead Sponsor:
Mayo Clinic
Conditions:
Gastroparesis
Healthy
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate potential mechanisms that could lead to the development of a condition known as gastroparesis.
Eligibility Criteria
Inclusion
- Adult patients (18-75 years old).
- Men and women.
- Patients with gastroparesis.
Exclusion
- Patients will be excluded from the study if symptoms are thought to represent an organic disorder (e.g., peptic ulcer disease, hepatitis, pancreatitis, inflammatory bowel disease, a known malignancy, radiation-induced injury, an active infection, vasculitis, celiac disease), GERD, esophagitis, eosinophilic esophagitis or H. pylori.
- Patients with uncontrolled diabetes mellitus (hemoglobin A1C \> 10).
- Patients with prior surgery to the esophagus, stomach or duodenum.
- Patients taking opioids, steroids, anti-histamines, immunosuppressive agents, NSAIDs, or mast cell stabilizing agents within the prior 3 months.
- Patients currently prescribed aspirin or aspirin regimens for other clinical reasons.
- Patients with known allergies to lactulose: mannitol will be excluded.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04894656
Start Date
April 1 2022
End Date
July 1 2023
Last Update
April 19 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.